1. Home
  2. GTIM vs LSTA Comparison

GTIM vs LSTA Comparison

Compare GTIM & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

N/A

Current Price

$1.21

Market Cap

13.7M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$5.02

Market Cap

16.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTIM
LSTA
Founded
1987
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
16.4M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
GTIM
LSTA
Price
$1.21
$5.02
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
29.4K
56.3K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.98
EPS
0.02
N/A
Revenue
$142,315,000.00
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$59.50
N/A
Revenue Growth
3.01
56.90
52 Week Low
$1.10
$1.81
52 Week High
$2.65
$5.05

Technical Indicators

Market Signals
Indicator
GTIM
LSTA
Relative Strength Index (RSI) 45.77 71.30
Support Level $1.16 $2.31
Resistance Level $1.25 N/A
Average True Range (ATR) 0.03 0.09
MACD -0.00 0.02
Stochastic Oscillator 21.46 95.19

Price Performance

Historical Comparison
GTIM
LSTA

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: